Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Quaker BioVentures

1.BioAdvance Ventures : Advisory Board   (100%):
Advisory Board BioAdvance Ventures will have access through Quaker BioVentures and through the Biotechnology Greenhouse of Southeastern Pennsylvania to several leading biotech executives and academic advisors. For more on information about our affiliates see ( www.quakerbio.com ) and ( www.bioadvanc...
2.BioAdvance Ventures   (83%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
3.BioAdvance Ventures   (83%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
4.BioAdvance Ventures : News : Press Releases : September 23, 2004   (72%):
News BioAdvance Ventures Announces Closing of $26 Million Early Stage Life Sciences Fund BioAdvance and Quaker BioVentures Partner to Attract More National Life Sciences Investment to Philadelphia Region Philadelphia and Wayne, PA - September 23, 2004 - BioAdvance, the Biotechnology Greenhouse of So...
5.Easton Capital Investment Group::EXIMIAS Pharmaceutical Corporation.   (66%):
EXIMIAS Pharmaceutical Corporation. EXIMIAS is a specialty pharmaceutical company that identifies, acquires, and develops unique prescription drugs to fulfill unmet medical needs in the therapeutic areas of Oncology and Infectious Disease. THYMITAQ, the Company s lead product, is a Phase III fast-tr...
6.BioAdvance, The Biotechnology Greenhouse of Southeastern Pennsylvania   (58%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, and will be managed by Quaker BioVentures Inc., ( www.quakerbio.com ). The Fund s goal is to pr...
7.BioAdvance Ventures : Team   (57%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Geeta Vemuri, Ph.D. Senior Associate Dr. Vemuri joined Quaker BioVentures as a Senior Associate in 2003. She brings years of experience in biomedical ...
8.BioAdvance Ventures : News : Press Releases : December 13, 2004   (55%):
News Neotropix Attracts $10 Million Series A Round For Development of Novel Virotherapies to Treat Cancer MALVERN, Pa.--(BUSINESS WIRE)--Dec. 13, 2004-- VIMAC Milestone Medica, Quaker BioVentures, and The Aurora Funds Co-lead Investment in Pennsylvania-based Company Neotropix(TM), Inc., a company de...
9.BioAdvance Ventures : News : Press Releases : November 22, 2004   (51%):
News Transport Pharmaceuticals Secures $27 Million in Venture Financing to Continue Development of Unique Drug Delivery Platform Carlyle Venture Partners and Quaker BioVentures co-lead Series D funding; Company's innovative oral herpes treatment ready for Phase III clinical trials Framingham, MA and...
10.BioAdvance Ventures : About Us   (50%):
About Us BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by...
11.BioAdvance Ventures : Team   (47%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Ira M. Lubert Managing Partner Mr. Lubert is a founding partner of Quaker BioVentures. He has over 17 years of experience in the venture capital indus...
12.BioAdvance Ventures : Team   (47%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team P. Sherrill Neff Managing Partner Mr. Neff is a founding partner of Quaker BioVentures, a $280 million Mid-Atlantic life sciences venture capital firm...
13.BioAdvance Ventures : Team   (47%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Richard Kollender Principal Mr. Kollender joined Quaker BioVentures as a Principal in early 2003. Previously, he worked at GlaxoSmithKline (GSK), wher...
14.BioAdvance   (47%):
About BioAdvance Management Team Board of Directors Fact Sheet Greenhouse Fund Process Eligibility Instructions Login Portfolio Companies BioAdvance Ventures Sponsored Initiatives BioInformatics Clinical Trials Consortium About the Region PA Life Sciences Initiative News Press Releases Articles Medi...
15.Abingworth - Portfolio Companies   (45%):
Portfolio Companies Abingworth Bioventures IIa ABVIIa is an annex fund to ABVII Abingworth Bioventures IV Abingworth Bioventures III Abingworth Bioventures IIa Abingworth Bioventures II Abingworth Bioventures Biotechnology Venture Fund
16.BioAdvance Ventures : News : Press Releases : April 22, 2005   (44%):
News TargetRx Announces $15 Million in Funding Led By Quaker BioVentures Pharmaceutical Marketing Information Company Continues Momentum Horsham, PA - April 22, 2005 - TargetRx, a marketing information services company that assists pharmaceutical companies in effectively selling and marketing their ...
17.BioAdvance Ventures : Team   (41%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Patrick Lee Analyst Mr. Lee joined Quaker BioVentures as an Analyst in 2004. Previously, he worked at Easton Associates, a management consulting firm ...
18.BioAdvance, The Biotechnology Greenhouse of Southeastern Pennsylvania   (35%):
Here is just a handful of success stories from several board members who believe in the Commonwealth’s $2 billion initiative that will strengthen Southeastern Pennsylvania’s position as a leader in life sciences innovation. “We are building a new spirit that will foster the growth...
19.Anthem Capital Management   (33%):
News | Current News Back to News Immune Control Raises $11.3 Million to Commence Two Clinical Trials Immune Control Raises $11.3 Million to Commence Two Clinical Trials PR Newswire July 14, 2005 Philadelphia, PA - Anthem Capital Management, an early-stage venture capital firm with offices in Philad...
20.BioAdvance Ventures : Team   (33%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Brenda D. Gavin Managing Partner Dr. Gavin is a founding partner of Quaker BioVentures. Previously, she was President of S.R. One, Limited (S.R. One),...

Page: 1   2   3   4   5   6   7   8  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others